CLINICAL_TRIALS trial_result · 2014-09-25

Clinical Trial Update: Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With Placebo [Phase 3]

Phase 3 trial evaluating LY450139 versus placebo for progression in Alzheimer's disease; results have been posted after completion in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Eli Lilly and Company | Conditions: Alzheimer's Disease | Phase 3 | Status: COMPLETED | Results posted: 2014-09-25